These results indicate that pharmacological inhibition of DDR via NU7441 significantly reduces IFI16 upregulation and ameliorates cardiac dysfunction and adverse remodeling in the doxorubicin-induced DCM model. The gene discussed is IFI16; the disease is familial dilated cardiomyopathy.